corylifol A

isolated from Psoralea corylifolia; structure in first source

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

1.	Muscular Atrophy (Muscle Atrophy) 01/06/2023 - "Bavachin and Corylifol A Improve Muscle Atrophy by Enhancing Mitochondria Quality Control in Type 2 Diabetic Mice." 10/01/2023 - "Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia." 01/06/2023 - "Therefore, bavachin and corylifol A exert potential therapeutic effects on muscle atrophy by suppressing inflammation and improving mitochondrial function."
2.	Neoplasms (Cancer) 10/01/2023 - "Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia."
3.	Cachexia 10/01/2023 - "Corylifol A ameliorates muscle atrophy by inhibiting TAOK1/p38-MAPK/FoxO3 pathway in cancer cachexia."
4.	Mitochondrial Diseases (Mitochondrial Disease) 08/15/2023 - "This study suggests that 4-hydroxylonchocarpin and corylifol A cause hepatocyte injury and apoptosis by inducing oxidative stress and mitochondrial dysfunction, suggesting that these compounds may be the potential hepatotoxic components of P. "
5.	Inflammation (Inflammations) 01/06/2023 - "Therefore, bavachin and corylifol A exert potential therapeutic effects on muscle atrophy by suppressing inflammation and improving mitochondrial function."

1.	p38 Mitogen-Activated Protein Kinases
2.	4-hydroxylonchocarpin
3.	Therapeutic Uses
4.	bavachin